Published on 16/11/2025

User Acceptance Testing (UAT) for EDC: Scripts, Defect Logs and Sign-Off

Introduction to User Acceptance Testing (UAT) in EDC

User Acceptance Testing (UAT) is a critical phase in the Electronic Data Capture (EDC) system lifecycle within clinical trials. It serves as the final validation step that ensures the system functions according to the requirements identified during the design phase. This guide outlines a comprehensive step-by-step approach to executing UAT for EDC, which is particularly crucial for clinical trials such as those conducted in the aegean clinical trial and other similar studies.

The goal of UAT is to confirm that the EDC system can meet all specified protocols pertaining to data management while ensuring that it adheres to regulatory standards laid out by organizations such as the FDA, EMA, and MHRA. As clinical trials continue to evolve with technological innovations, it becomes imperative for clinical operations, regulatory affairs, and medical affairs professionals to understand and implement effective UAT processes.

Step 1: Establish UAT Objectives and Scope

The first step in the UAT process is to establish clear objectives and scope. This includes defining what aspects of the EDC system will be tested, detailing outcomes that are expected from the testing, and outlining the user profiles for validation. The objectives of UAT may include:

• Verifying that the EDC system is intuitive and user-friendly for clinical personnel.
• Ensuring that all system functionalities operate accurately as per business requirements.
• Identifying any discrepancies or defects that may have emerged from previously conducted testing phases.

Once objectives are set, it is vital to scope the UAT to focus on critical functions relevant to trial data management. This scope often encompasses system navigation, data entry, editing, and reporting capabilities, particularly as they pertain to site management organization clinical research.

Step 2: Design UAT Scripts

UAT scripts are formal documents that guide the testers in executing test cases effectively. Each script should correspond directly to specific functionalities outlined in the requirements documentation. Scripts should be created with the following guidelines in mind:

• Each script must start with a clear objective statement outlining the functionality being tested.
• Detail the prerequisites for executing the script, including system access and data load.
• Outline the step-by-step instructions for executing the test.
• Include expected results for each step to compare against actual results.

For example, a script for an eDiary clinical trial might include sections that guide the tester in logging in, entering data, editing a diary entry, and generating reports. This attention to detail will ultimately facilitate a systematic and thorough testing approach.

Step 3: Prepare the Testing Environment

A controlled testing environment is essential to conduct UAT effectively. The testing environment must reflect the production environment as closely as possible to ensure accurate results. Preparation steps may include:

• Configuring the EDC system with the appropriate data sets and user roles.
• Ensuring that all functionalities planned for testing are activated.
• Validating system performance to confirm that it meets defined performance criteria.

Prior to commencing testing, it is imperative to educate the users on their role and the testing process. This training should cover system navigation, the importance of accurate data entry, and the protocol surrounding defect reporting.

Step 4: Execute UAT

With the UAT scripts prepared and the testing environment set up, it is time to execute the tests. During this phase, testers will use the scripted scenarios to interact with the EDC system. It is critical for testers to document their findings meticulously. Important aspects to monitor include:

• Any workflow interruptions or system errors encountered.
• Functionality that does not align with the prespecified expectations.
• User experience feedback regarding system usability.

This phase of UAT serves as an opportunity not just to identify defects, but also to understand user interaction with the system. This insight is invaluable for refining the way the EDC system is configured in real-time clinical operations.

Step 5: Documenting Defects and Issues

As defects are uncovered, they must be documented in a systematic manner. This includes establishing a defect log that captures essential details such as:

• Defect ID and type (critical, major, minor).
• Detailed description of the defect and steps to reproduce it.
• Severity of the defect and its potential impact on clinical trial processes.
• Current status of defect resolution efforts.

This defect log will be crucial for subsequent review and corrective actions and serves as evidence in compliance documentation, demonstrating adherence to clinical trial regulations.

Step 6: Review and Validate UAT Results

Once UAT has been executed and defects documented, the next step is to review and validate the results. This entails a collaborative meeting with stakeholders including project managers, data managers, and quality assurance personnel. Key activities during this review include:

• Assessing the logged defects and categorizing them by severity and impact.
• Deciding on the prioritization of defect resolution and re-testing.
• Communicating any critical defects that could impede trial initiation.

Through thorough validation, the team can determine if UAT objectives have been met and if the EDC system is ready for production. This review also helps ensure compliance with ICH-GCP guidelines and regulatory requirements from bodies such as EMA and MHRA.

Step 7: Obtain User Sign-Off

Upon successful completion of the UAT, obtaining user sign-off is the final step. This formal approval indicates that the users affirm the system’s readiness for production use. The sign-off document should include:

• Confirmation that all critical defects have been resolved.
• A summary of UAT findings and actions taken.
• Signatures from designated personnel including project managers and key stakeholders.

This sign-off acts as an essential piece of documentation required for regulatory compliance and is also a safeguard for liability and accountability, ensuring that all parties have agreed to the EDC system’s operational integrity.

Conclusion: Best Practices and Final Thoughts

The implementation of a robust User Acceptance Testing process is not merely a formality in the EDC lifecycle but a fundamental aspect that can significantly influence the overall success of clinical trials, such as the mariposa clinical trial. By following a structured approach as outlined above, clinical operations, regulatory affairs, and medical affairs professionals can ensure that EDC systems not only meet functional specifications but also contribute to high-quality data integrity and compliance.

Throughout this tutorial, we have emphasized key phases of UAT in EDC from establishing objectives to obtaining user sign-off. Adapting these principles ensures the EDC system is reliable, user-friendly, and ultimately effective in supporting clinical research. As technology continues to evolve, adapting UAT processes to incorporate new methodologies will remain essential in maintaining the integrity of clinical trial data.